BioSpace News Archive

ColdQuanta, the quantum atomics company, was selected as one of only three industry partners for the Department of Energy (DOE) Quantum Science Center (QSC), under the collaboration headed by Oak Ridge National Laboratory (ORNL)

Artelo Biosciences, Inc. today announced that it will be presenting at the LD 500 Virtual Investor conference being held on September 1-4, 2020.

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, and KYE Pharmaceuticals Inc. (“KYE”), a private company headquartered in Mississauga, Ontario and focused on bringing medicines that fulfill clinically significant unmet needs to the Canadian ma

11.2 Ventures ( www.11-2ventures.com) one of only a handful of venture builder studios (VBS) in the U.S., has recently acquired the assets of Chicago-based K8 Ventures for $9.65 million.

JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has successfully completed its initial

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced that it has

The Net Profit Attributable to Shareholders Increased 13.1% as Compared to the Same Period in 2019 with Innovation Transformation and Integrated Operation Actively Promoted [26-August-2020] SHANGHAI , Aug. 26, 2020 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma"; Stock Code: 600196.SH, 02196.HK) , a leading healthcare group in Chin

Biorasi , a leading global full-service contract research organization (CRO), has been named on the Inc. 5000 list of the fastest-growing private companies for 2020. This prestigious ranking from Inc. magazine distinguishes Biorasi as an industry leader in the health services and clinical trial management industries. “Biorasi is honored to be included in the Inc. 5000 again this year,” said Scott Nenninger, CFO at Biorasi.

Aligos Therapeutics, Inc. (Aligos), a private biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B (CHB), COVID-19 and therapeutics for nonalcoholic steatohepatitis (NASH), will present nonclinical data related to the company’s thyroid hormone receptor-beta (THR-B) therapeutic program for NASH on August 27 at the European Associa

Mopec, the nationwide leader in pathology, anatomy, mortuary and necropsy equipment and supplies, introduced their newest product, the Mopec 810 Autopsy Saw , addressing the demand that has existed since March of this year.